CD8A and cancer: Accumulating evidence revealed that m6A mRNA methylation participates in the pathogenesis and progression of cancers through molecular mechanisms, such as inhibiting the antitumor response of CD8+ T cells (Chen et al., 2019; Sun et al., 2019).